Glucagon-like peptide-1 analogues - an efficient therapeutic option for the severe insulin resistance of lipodystrophic syndromes: two case reports

Peer Review reports

Original Submission
22 Sep 2016	Submitted	Original manuscript
14 Oct 2016	Reviewed	Reviewer Report - damian romero
25 Oct 2016	Reviewed	Reviewer Report - Licy L. Yanes Cardozo
13 Nov 2016	Author responded	Author comments - Joana Oliveira
Resubmission - Version 2
13 Nov 2016	Submitted	Manuscript version 2
Publishing
11 Dec 2016	Editorially accepted
13 Jan 2017	Article published	10.1186/s13256-016-1175-1

Back to article page